Specialist healthcare investor GHO Capital has bought RoslinCT, a contract development and management organisation spinout focused on advanced cell therapies.
Specialist healthcare investor GHO Capital has bought RoslinCT, a contract development and management organisation spinout focused on advanced cell therapies.